Cargando…
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
BACKGROUND: It is now recognized that preterm infants ≤28 weeks gestation can be effectively supported from the outset with nasal continuous positive airway pressure. However, this form of respiratory therapy may fail to adequately support those infants with significant surfactant deficiency, with t...
Autores principales: | Dargaville, Peter A, Kamlin, Camille Omar F, De Paoli, Antonio G, Carlin, John B, Orsini, Francesca, Soll, Roger F, Davis, Peter G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236682/ https://www.ncbi.nlm.nih.gov/pubmed/25164872 http://dx.doi.org/10.1186/1471-2431-14-213 |
Ejemplares similares
-
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial
por: Francis, Kate L, et al.
Publicado: (2023) -
Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial
por: Manley, Brett J., et al.
Publicado: (2023) -
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
por: Ng, Sze M, et al.
Publicado: (2008) -
Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art
por: Erdeve, Ömer, et al.
Publicado: (2021) -
Portrait of an optimist
por: Sette, Alessandro
Publicado: (2017)